Cargando…
Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer()
Oral cancer has been recognized as a tumor with low sensitivity to anticancer agents. However, introduction of S-1, an oral cancer agent is improving treatment outcome for patients with oral cancer. In addition, S-1, as a main drug for oral cancer treatment in Japan can be easily available for outpa...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501734/ https://www.ncbi.nlm.nih.gov/pubmed/28725297 http://dx.doi.org/10.1016/j.jdsr.2016.11.001 |